In a filing earlier this week, a Chinese tech company laid out its case for an injunction in relation to a Trump administration decision to designate it as a "Chinese Military Company," focusing on first amendment speech issues.

In a filing earlier this week, a Chinese biotech company laid out its case for asking a court to enjoin a Trump administration decision to designate it as a "Chinese Military Company."

Adding to the growing list of complaints against the designation of companies as a "Chinese Military Company" (CMC), tech giant Alibaba has filed a lawsuit against the Trump administration in federal district court in the Northern District of California, challenging the designation made earlier this month.

Last month, the Chongqing Intermediate People's Court underscored China’s expanding judicial reach in intellectual property by issuing a global FRAND (Fair, Reasonable, and Non-Discriminatory) rate-setting judgment in the Samsung-ZTE standard-essential patent (SEP) dispute. The court ruling adds another layer of complexity to a

In the third lawsuit of its kind filed against Washington’s national security blacklists, global pharmaceutical and life sciences giant WuXi AppTec Co., Ltd. has filed a federal lawsuit challenging its designation as a "Chinese Military Company" (CMC).

In an order issued today, the U.S. Supreme Court declined to hear an appeal related to the Section 301 tariffs originally imposed on Chinese imports during President Trump's first term. This leaves the appeals court decision in the case as the final word on the matter for

Chinese wind turbine manufacturer Goldwind has filed a legal challenge against an investigation conducted under the bloc's Foreign Subsidies Regulation (FSR), marking the latest dispute over the European Commission's authority to seek information from companies during the investigation.